A Phase 3 Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis
Phase 3
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2019-11-25
- Last Posted Date
- 2024-01-09
- Lead Sponsor
- Everstar Therapeutics Limited
- Target Recruit Count
- 341
- Registration Number
- NCT04176588
- Locations
- 🇨🇳
The First Affiliated Hospital of Fourth Military Medical University, PLA, Xi'an, Shanxi, China
© Copyright 2024. All Rights Reserved by MedPath